David Couper

43.9k total citations · 7 hit papers
258 papers, 16.2k citations indexed

About

David Couper is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, David Couper has authored 258 papers receiving a total of 16.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Cardiology and Cardiovascular Medicine, 53 papers in Pulmonary and Respiratory Medicine and 43 papers in Epidemiology. Recurrent topics in David Couper's work include Retinal Imaging and Analysis (29 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (29 papers) and Retinal Diseases and Treatments (26 papers). David Couper is often cited by papers focused on Retinal Imaging and Analysis (29 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (29 papers) and Retinal Diseases and Treatments (26 papers). David Couper collaborates with scholars based in United States, Australia and Brazil. David Couper's co-authors include Ronald Klein, Tien Yin Wong, A. Richey Sharrett, Gerardo Heiss, Bruce Bartholow Duncan, Christie M. Ballantyne, James S. Pankow, Larry D. Hubbard, Aaron R. Folsom and Ron C. Hoogeveen and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

David Couper

243 papers receiving 15.7k citations

Hit Papers

Combined Pharmacotherapie... 2001 2026 2009 2017 2006 2003 2002 2001 2016 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence
    2006 1.3k citations David Couper et al. profile →
  2. Low-Grade Systemic Inflammation and the Development of Type 2 Diabetes
    2003 847 citations James S. Pankow, Christie M. Ballantyne et al. profile →
  3. Retinal Arteriolar Narrowing and Risk of Coronary Heart Disease in Men and Women
    2002 624 citations Tien Yin Wong, Ronald Klein et al. profile →
  4. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study
    2001 601 citations Tien Yin Wong, Ronald Klein et al. profile →
  5. Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function
    2016 418 citations Prescott G. Woodruff, Eugene R. Bleecker et al. profile →
  6. Small Dense Low-Density Lipoprotein-Cholesterol Concentrations Predict Risk for Coronary Heart Disease
    2014 385 citations Ron C. Hoogeveen, Wensheng Sun et al. profile →
  7. The ARIC (Atherosclerosis Risk In Communities) Study
    2021 297 citations Aaron R. Folsom, Josef Coresh et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David Couper 3.5k 3.3k 3.2k 2.7k 2.5k 258 16.2k
F. Javier Nieto 1.7k 0.5× 2.7k 0.8× 1.7k 0.5× 1.4k 0.5× 1.5k 0.6× 106 12.6k
Astrid Fletcher 2.6k 0.7× 6.1k 1.8× 2.1k 0.7× 3.1k 1.1× 1.5k 0.6× 214 16.5k
Yutaka Kiyohara 3.0k 0.9× 3.2k 1.0× 1.1k 0.4× 918 0.3× 3.2k 1.3× 291 16.6k
Nish Chaturvedi 2.2k 0.6× 6.0k 1.8× 2.2k 0.7× 2.1k 0.8× 2.5k 1.0× 409 19.4k
A. Richey Sharrett 3.6k 1.0× 9.3k 2.8× 7.0k 2.2× 5.6k 2.1× 2.0k 0.8× 230 25.4k
Kyungdo Han 3.9k 1.1× 4.5k 1.3× 1.1k 0.3× 892 0.3× 3.2k 1.3× 1.2k 20.4k
Greg Gamble 1.5k 0.4× 3.8k 1.1× 1.4k 0.4× 820 0.3× 1.2k 0.5× 376 16.4k
Eyal Shahar 3.2k 0.9× 7.0k 2.1× 1.9k 0.6× 890 0.3× 8.6k 3.4× 172 23.1k
Tatjana Rundek 4.6k 1.3× 7.2k 2.2× 1.9k 0.6× 515 0.2× 1.7k 0.7× 511 18.8k
Pesus Chou 2.3k 0.7× 1.5k 0.5× 1.4k 0.4× 1.8k 0.7× 1.0k 0.4× 315 10.8k

Countries citing papers authored by David Couper

Since Specialization
Citations

This map shows the geographic impact of David Couper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Couper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Couper more than expected).

Fields of papers citing papers by David Couper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Couper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Couper. The network helps show where David Couper may publish in the future.

Co-authorship network of co-authors of David Couper

This figure shows the co-authorship network connecting the top 25 collaborators of David Couper. A scholar is included among the top collaborators of David Couper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Couper. David Couper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Localio, A. Russell, Stephanie Chang, Anne R. Meibohm, et al.. (2025). Standardization and Prediction to Control Confounding: Estimating Risk Differences and Ratios for Clinical Interpretations and Decision Making. Annals of Internal Medicine. 178(6). 829–835. 1 indexed citations
2.
Li, Chenxi, Anna Kucharska‐Newton, Zhehui Luo, et al.. (2025). Poor olfaction and risk of heart failure in the Atherosclerosis Risk in Communities Study. The Journals of Gerontology Series A. 80(11).
3.
Pike, James Russell, Alison Huang, Nicholas S. Reed, et al.. (2025). Cognitive benefits of hearing intervention vary by risk of cognitive decline: A secondary analysis of the ACHIEVE trial. Alzheimer s & Dementia. 21(5). e70156–e70156. 1 indexed citations
4.
Li, Chenxi, Anna Kucharska‐Newton, Zhehui Luo, et al.. (2025). Poor Olfaction and Risk of Stroke in Older Adults: The Atherosclerosis Risk in Communities Study. Stroke. 56(2). 465–474. 2 indexed citations
5.
Prizment, Anna E., Conghui Qu, Shuo Wang, et al.. (2025). Functional variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene are associated with increased risk of colorectal cancer. Human Molecular Genetics. 34(7). 617–625. 1 indexed citations
6.
Li, Chenxi, David Couper, Srishti Shrestha, et al.. (2025). Olfactory Function and Frailty in Older Adults. The Journals of Gerontology Series A. 80(4). 1 indexed citations
7.
8.
Marrone, Michael, Anna E. Prizment, David Couper, et al.. (2023). Total‐, LDL‐, and HDL‐cholesterol, apolipoproteins, and triglycerides with risk of total and fatal prostate cancer in Black and White men in the ARIC study. The Prostate. 83(11). 1046–1059. 3 indexed citations
9.
Wang, Shuo, Nathan Pankratz, Heather H. Nelson, et al.. (2023). Associations between MICA and MICB Genetic Variants, Protein Levels, and Colorectal Cancer: Atherosclerosis Risk in Communities (ARIC). Cancer Epidemiology Biomarkers & Prevention. 32(6). 784–794. 2 indexed citations
10.
Wang, Anqi, Mariana Lazo, Jiayun Lu, et al.. (2023). Liver Fibrosis Scores and Prostate Cancer Risk and Mortality in the Atherosclerosis Risk in Communities Study. Cancer Prevention Research. 16(9). 523–530. 2 indexed citations
11.
Huang, Alison, Nicholas S. Reed, Jennifer A. Deal, et al.. (2023). Depression and Health-Related Quality of Life Among Older Adults With Hearing Loss in the ACHIEVE Study. Journal of Applied Gerontology. 43(5). 550–561. 6 indexed citations
12.
Pletcher, Mark J., Natalie R. Hasbani, David Couper, et al.. (2023). Coronary heart disease and ischemic stroke polygenic risk scores and atherosclerotic cardiovascular disease in a diverse, population-based cohort study. PLoS ONE. 18(6). e0285259–e0285259. 3 indexed citations
13.
Liu, Wei, Kavita Patel, Yi Wang, et al.. (2023). Dynamic and functional linkage between von Willebrand factor and ADAMTS-13 with aging: an Atherosclerosis Risk in Community study. Journal of Thrombosis and Haemostasis. 21(12). 3371–3382. 8 indexed citations
14.
Buhr, Russell G., Igor Barjaktarević, P. Miguel Quibrera, et al.. (2022). Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study. American Journal of Respiratory and Critical Care Medicine. 206(5). 554–562. 22 indexed citations
15.
Steffen, Brian T., Weihong Tang, Pamela L. Lutsey, et al.. (2022). Proteomic analysis of diabetes genetic risk scores identifies complement C2 and neuropilin-2 as predictors of type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetologia. 66(1). 105–115. 12 indexed citations
16.
Jia, Xiaoming, Wensheng Sun, Ron C. Hoogeveen, et al.. (2019). High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study. Circulation. 139(23). 2642–2653. 152 indexed citations
17.
Folsom, Aaron R., Weihong Tang, Saonli Basu, et al.. (2019). Plasma Concentrations of High Molecular Weight Kininogen and Prekallikrein and Venous Thromboembolism Incidence in the General Population. Thrombosis and Haemostasis. 119(5). 834–843. 10 indexed citations
18.
Zhang, Zhu-Ming, Pentti M. Rautaharju, Ronald J. Prineas, et al.. (2016). Race and Sex Differences in the Incidence and Prognostic Significance of Silent Myocardial Infarction in the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 133(22). 2141–2148. 76 indexed citations
19.
Lubin, Jay H., David Couper, Pamela L. Lutsey, et al.. (2016). Risk of Cardiovascular Disease from Cumulative Cigarette Use and the Impact of Smoking Intensity. Epidemiology. 27(3). 395–404. 79 indexed citations
20.
Wong, Tien Yin, Ronald Klein, A. Richey Sharrett, et al.. (2004). Diabetic Retinopathy and Risk of Ischemic Stroke: The Atherosclerosis Risk in Communities Study. Investigative Ophthalmology & Visual Science. 45(13). 5242–5242. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Javier Nieto Breakdown of academic impact, for papers by Astrid Fletcher Breakdown of academic impact, for papers by Yutaka Kiyohara Breakdown of academic impact, for papers by Nish Chaturvedi Breakdown of academic impact, for papers by A. Richey Sharrett Breakdown of academic impact, for papers by Kyungdo Han Breakdown of academic impact, for papers by Greg Gamble Breakdown of academic impact, for papers by Eyal Shahar Breakdown of academic impact, for papers by Tatjana Rundek Breakdown of academic impact, for papers by Pesus Chou
Rankless by CCL
2026